Related Experiment Video
Updated: May 30, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Obesity and obstetric anaesthesia.
H S Mace1, M J Paech, N J McDonnell
1Department of Anaesthesia and Pain Medicine, King Edward Memorial Hospital for Women, Perth, Western Australia, Australia.
Anaesthesia and Intensive Care
|August 10, 2011
Summary
Obesity in pregnancy poses significant risks, including diabetes and heart disease. Management for labor and delivery requires special consideration due to increased risks with anesthesia and operative delivery.
Area of Science:
- Obstetrics and Gynecology
- Anesthesiology
- Public Health
Background:
- Rising obesity rates impact the general population and are particularly concerning in pregnant women.
- Pregnancy exacerbates existing obesity-related physiological changes, especially in cardiovascular and respiratory systems.
- Obesity during pregnancy increases risks for conditions like diabetes, hypertension, and congenital malformations.
Purpose of the Study:
- To summarize the physiological and pharmacological implications of obesity in pregnancy.
- To describe the challenges and considerations for managing labor and delivery in obese pregnant women.
Main Methods:
- Literature review and synthesis of existing research on obesity, pregnancy, and anesthesia.
- Analysis of physiological changes during pregnancy in obese individuals.
- Review of anesthetic techniques and associated risks.
Main Results:
- Obese pregnant women face higher risks of gestational diabetes, hypertensive disorders, and thromboembolism.
- Cesarean delivery and general anesthesia in obese women are associated with increased morbidity and mortality.
- Regional analgesia and anesthesia, while preferred, can be technically challenging in this population.
Conclusions:
- Obesity significantly complicates pregnancy, increasing maternal and fetal risks.
- Anesthesia management for labor and delivery in obese women requires careful planning to mitigate complications.
- Further research is needed to optimize care for obese pregnant individuals.
Related Concept Videos
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:07Intestinal Obstruction II: Pathophysiology
Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...